Dr. Xin Ji 季鑫
Chief Physician, Associate Professor
Gastrointestinal Tumor Center, Ward 1, Peking University Cancer Hospital, Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and comprehensive treatment of gastric, esophagogastric junction, colorectal cancers, and gastrointestinal stromal tumors. Specializes in minimally invasive (laparoscopic and robotic) surgery, anti-reflux procedures after gastrectomy, reduced surgery for early gastric cancer, and sphincter-preserving surgery for low rectal cancer.
Dr. Ji earned a MD/PhD from Peking University Health Science Center in 2010 and has worked at Peking University Cancer Hospital since. Dr. Ji was a visiting scholar at Stanford University Medical Center in 2019. Research focuses on gastric cancer surgery. Dr. Ji received the First Prize of the Chinese Medical Association Medical Science and Technology Award in 2024.
Professional roles
- Member, International Gastric Cancer Association
- Member, Minimally Invasive Surgery Committee, Surgical Branch of Chinese Medical Doctor Association
- Member, Tumor Critical Care Medicine Professional Committee, Beijing Anti-Cancer Association
- Member, Ethics Committee, Peking University Cancer Hospital
Name order: in Chinese the family name comes first (Ji Xin). Papers usually list the name as Xin Ji or Ji X.
Selected publications
44 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancer Res Treat, 2021 (first author): Double Tract Reconstruction Reduces Reflux Esophagitis and Improves Quality of Life after Radical Proximal Gastrectomy for Patients with Upper Gastric or Esophagogastric Adenocarcinoma. PubMed 33421979
- Gastric Cancer, 2018 (first author): The 8th edition of the American Joint Committee on Cancer tumor-node-metastasis staging system for gastric cancer is superior to the 7th edition: results from a Chinese mono-institutional study of 1663 patients. PubMed 29168120
- BMC Cancer, 2017 (first author): Prognostic significance of the total number of harvested lymph nodes for lymph node-negative gastric cancer patients. PubMed 28830455
- BMC Cancer, 2017 (first author): The optimal extent of gastrectomy for middle-third gastric cancer: distal subtotal gastrectomy is superior to total gastrectomy in short-term effect without sacrificing long-term survival. PubMed 28526077
- BMC Cancer, 2016 (first author): Comparison of different methods of splenic hilar lymph node dissection for advanced upper- and/or middle-third gastric cancer. PubMed 27716191
- Zhonghua Wei Chang Wai Ke Za Zhi, 2013 (first author): [Treatment progress of gastrointestinal stromal tumor]. PubMed 23536354
- Zhonghua Wei Chang Wai Ke Za Zhi, 2011 (first author): [Expression of human epidermal growth factor receptor 2 in gastroesophageal cancer with different scoring systems and its relationship with clinicopathological features]. PubMed 21614691
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion